Share Price and Basic Stock Data
Last Updated: November 26, 2025, 6:52 pm
| PEG Ratio | 2.40 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Axel Polymers Ltd operates within the plastics sector, focusing on the production of plastic and plastic products. The company reported a market capitalization of ₹40.0 Cr and a current share price of ₹47.0. Over the last fiscal year, Axel Polymers demonstrated significant revenue growth, with sales rising from ₹72.91 Cr in March 2022 to ₹82.65 Cr in March 2023, and projected revenues of ₹127.92 Cr for March 2024. Quarterly sales figures also reflected this upward trajectory, with the latest reported quarterly sales reaching ₹38.65 Cr in December 2023, following ₹30.92 Cr in September 2023. However, the trailing twelve months (TTM) sales stood at ₹47.86 Cr, indicating a notable decline from the previous year’s performance. The company has exhibited variability in quarterly performance, with fluctuations in sales that could prompt concerns regarding stability and predictability in revenue generation.
Profitability and Efficiency Metrics
In terms of profitability, Axel Polymers reported an Operating Profit Margin (OPM) of 8.55%, which is relatively modest compared to industry averages. The operating profit has shown fluctuations, peaking at ₹5.12 Cr for March 2023 and declining to ₹3.96 Cr for March 2025. The company’s net profit stood at ₹1.52 Cr, with a net profit margin of 0.22% for March 2025, reflecting challenges in maintaining profitability amidst rising expenses. The Interest Coverage Ratio (ICR) was reported at 1.27x, indicating that the company barely meets its interest obligations, which raises concerns about financial flexibility. The Cash Conversion Cycle (CCC) stood at 175.64 days, suggesting potential inefficiencies in managing working capital and inventory, which may strain liquidity and operational efficiency over time.
Balance Sheet Strength and Financial Ratios
Axel Polymers’ balance sheet reflects a total debt-to-equity ratio of 2.25x, indicating a high level of financial leverage. This level of indebtedness raises concerns about financial stability, particularly in an environment of rising interest rates. The company’s return on equity (ROE) was reported at 1.13%, significantly below many industry peers, suggesting that the company is not efficiently utilizing shareholders’ equity to generate profits. Furthermore, the book value per share increased to ₹17.77 for March 2025, marking a positive trend in shareholder value. However, the company’s interest coverage ratio, combined with a current ratio of 1.19x, suggests that while short-term liquidity is manageable, the long-term financial health could be jeopardized if operational performance does not improve significantly.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Axel Polymers indicates a strong promoter holding of 61.16%, which may provide stability and confidence to investors. However, the presence of institutional investors remains minimal, with Foreign Institutional Investors (FIIs) not participating and Domestic Institutional Investors (DIIs) holding only 0.24%. The public shareholding stands at 38.61%, with a total of 10,067 shareholders. This distribution suggests that while promoters maintain control, the lack of institutional support may limit growth prospects and market confidence. Over recent quarters, the number of shareholders has fluctuated slightly, reflecting an overall stable interest among retail investors, although the absence of institutional backing may indicate caution among larger, more strategic investors.
Outlook, Risks, and Final Insight
The outlook for Axel Polymers appears mixed, with opportunities for growth tempered by significant risks. The anticipated revenue growth to ₹127.92 Cr for March 2024 presents a positive trajectory; however, the company’s declining profitability and high debt levels pose substantial risks. With an OPM of 8.55% and a low ROE of 1.13%, the company must improve operational efficiency to enhance profitability. Additionally, the high Cash Conversion Cycle of 175.64 days indicates potential liquidity issues that could hinder growth. Investors should remain vigilant regarding these risks while monitoring the company’s efforts to stabilize and grow its financial performance. If Axel Polymers can effectively manage its operational challenges and leverage its existing strengths, it may navigate through this transitional phase successfully. Conversely, failure to address these issues could lead to further declines in investor confidence and market performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Axel Polymers Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IIRM Holdings India Ltd | 511 Cr. | 75.0 | 135/69.7 | 27.8 | 21.3 | 0.00 % | 23.5 % | 18.6 % | 5.00 |
| Fiberweb (India) Ltd | 108 Cr. | 37.8 | 66.0/34.0 | 6.69 | 63.9 | 0.00 % | 10.0 % | 8.88 % | 10.0 |
| Deep Polymers Ltd | 104 Cr. | 43.1 | 74.2/35.7 | 21.0 | 37.5 | 0.00 % | 8.22 % | 6.10 % | 10.0 |
| DDev Plastiks Industries Ltd | 2,869 Cr. | 277 | 360/213 | 14.5 | 88.5 | 0.63 % | 33.9 % | 24.9 % | 1.00 |
| Bright Brothers Ltd | 162 Cr. | 286 | 495/264 | 20.4 | 141 | 0.88 % | 16.2 % | 11.5 % | 10.0 |
| Industry Average | 1,631.17 Cr | 482.73 | 37.58 | 190.74 | 0.31% | 16.69% | 12.44% | 8.13 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.82 | 21.45 | 17.74 | 27.18 | 25.81 | 30.92 | 38.65 | 37.28 | 42.24 | 13.87 | 11.11 | 14.33 | 11.70 |
| Expenses | 17.79 | 20.42 | 16.58 | 25.29 | 24.28 | 29.53 | 37.18 | 35.85 | 41.93 | 13.72 | 10.95 | 11.03 | 10.70 |
| Operating Profit | 1.03 | 1.03 | 1.16 | 1.89 | 1.53 | 1.39 | 1.47 | 1.43 | 0.31 | 0.15 | 0.16 | 3.30 | 1.00 |
| OPM % | 5.47% | 4.80% | 6.54% | 6.95% | 5.93% | 4.50% | 3.80% | 3.84% | 0.73% | 1.08% | 1.44% | 23.03% | 8.55% |
| Other Income | 0.05 | 0.08 | 0.03 | 0.12 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.09 | 0.01 |
| Interest | 0.72 | 0.76 | 0.82 | 0.86 | 0.80 | 0.78 | 0.67 | 0.62 | 0.75 | 0.85 | 0.81 | 0.82 | 0.82 |
| Depreciation | 0.10 | 0.10 | 0.10 | 0.24 | 0.12 | 0.12 | 0.12 | 0.34 | 0.12 | 0.12 | 0.12 | 0.20 | 0.15 |
| Profit before tax | 0.26 | 0.25 | 0.27 | 0.91 | 0.62 | 0.50 | 0.69 | 0.48 | -0.53 | -0.81 | -0.76 | 2.37 | 0.04 |
| Tax % | 0.00% | 0.00% | 0.00% | 54.95% | 0.00% | 0.00% | 2.90% | 114.58% | 0.00% | 0.00% | 0.00% | 5.91% | 0.00% |
| Net Profit | 0.26 | 0.25 | 0.27 | 0.41 | 0.62 | 0.50 | 0.67 | -0.07 | -0.53 | -0.81 | -0.76 | 2.23 | 0.04 |
| EPS in Rs | 0.31 | 0.29 | 0.32 | 0.48 | 0.73 | 0.59 | 0.79 | -0.08 | -0.62 | -0.95 | -0.89 | 2.62 | 0.05 |
Last Updated: August 1, 2025, 6:50 am
Below is a detailed analysis of the quarterly data for Axel Polymers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 11.70 Cr.. The value appears to be declining and may need further review. It has decreased from 14.33 Cr. (Mar 2025) to 11.70 Cr., marking a decrease of 2.63 Cr..
- For Expenses, as of Jun 2025, the value is 10.70 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.03 Cr. (Mar 2025) to 10.70 Cr., marking a decrease of 0.33 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.30 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 2.30 Cr..
- For OPM %, as of Jun 2025, the value is 8.55%. The value appears to be declining and may need further review. It has decreased from 23.03% (Mar 2025) to 8.55%, marking a decrease of 14.48%.
- For Other Income, as of Jun 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.09 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.08 Cr..
- For Interest, as of Jun 2025, the value is 0.82 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.82 Cr..
- For Depreciation, as of Jun 2025, the value is 0.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.20 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.05 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 2.37 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 2.33 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 5.91% (Mar 2025) to 0.00%, marking a decrease of 5.91%.
- For Net Profit, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 2.23 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 2.19 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.05. The value appears to be declining and may need further review. It has decreased from 2.62 (Mar 2025) to 0.05, marking a decrease of 2.57.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:51 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.56 | 16.19 | 18.53 | 21.94 | 26.97 | 24.37 | 22.90 | 48.32 | 72.91 | 82.65 | 127.92 | 78.09 | 47.86 |
| Expenses | 6.05 | 14.74 | 17.37 | 20.81 | 25.65 | 22.71 | 21.51 | 44.41 | 68.80 | 77.53 | 122.12 | 74.13 | 42.47 |
| Operating Profit | -0.49 | 1.45 | 1.16 | 1.13 | 1.32 | 1.66 | 1.39 | 3.91 | 4.11 | 5.12 | 5.80 | 3.96 | 5.39 |
| OPM % | -8.81% | 8.96% | 6.26% | 5.15% | 4.89% | 6.81% | 6.07% | 8.09% | 5.64% | 6.19% | 4.53% | 5.07% | 11.26% |
| Other Income | 0.03 | 0.04 | 0.08 | 0.27 | 0.04 | 0.02 | 0.02 | 0.40 | 0.55 | 0.28 | 0.04 | 0.14 | 0.13 |
| Interest | 0.87 | 0.88 | 0.84 | 0.93 | 0.79 | 0.91 | 0.97 | 3.32 | 2.84 | 3.16 | 2.85 | 3.23 | 3.24 |
| Depreciation | 0.45 | 0.48 | 0.25 | 0.21 | 0.28 | 0.33 | 0.36 | 0.42 | 0.48 | 0.54 | 0.70 | 0.56 | 0.62 |
| Profit before tax | -1.78 | 0.13 | 0.15 | 0.26 | 0.29 | 0.44 | 0.08 | 0.57 | 1.34 | 1.70 | 2.29 | 0.31 | 1.66 |
| Tax % | 0.00% | 0.00% | 0.00% | 15.38% | 17.24% | -6.82% | -12.50% | -15.79% | 31.34% | 30.59% | 31.88% | 41.94% | |
| Net Profit | -1.78 | 0.12 | 0.15 | 0.22 | 0.23 | 0.47 | 0.09 | 0.66 | 0.92 | 1.18 | 1.56 | 0.17 | 1.52 |
| EPS in Rs | -4.14 | 0.28 | 0.35 | 0.51 | 0.53 | 1.09 | 0.21 | 1.53 | 1.08 | 1.39 | 1.83 | 0.20 | 1.79 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 106.74% | 25.00% | 46.67% | 4.55% | 104.35% | -80.85% | 633.33% | 39.39% | 28.26% | 32.20% | -89.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | -81.74% | 21.67% | -42.12% | 99.80% | -185.20% | 714.18% | -593.94% | -11.13% | 3.94% | -121.31% |
Axel Polymers Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 28% |
| 3 Years: | 2% |
| TTM: | -66% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 14% |
| 3 Years: | -43% |
| TTM: | 23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 40% |
| 3 Years: | 8% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | 7% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:31 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 158.87 | 123.32 | 86.08 | 33.94 | 36.68 | 26.36 | 33.47 | 100.01 | 57.02 | 33.87 | 31.19 | 51.56 |
| Inventory Days | 130.41 | 127.01 | 102.73 | 123.25 | 113.12 | 146.24 | 184.09 | 218.96 | 166.83 | 168.33 | 125.70 | 215.52 |
| Days Payable | 180.68 | 175.90 | 38.81 | 36.63 | 19.49 | 20.20 | 62.21 | 125.81 | 95.43 | 80.23 | 71.47 | 91.43 |
| Cash Conversion Cycle | 108.60 | 74.43 | 150.00 | 120.56 | 130.30 | 152.40 | 155.35 | 193.16 | 128.43 | 121.97 | 85.42 | 175.64 |
| Working Capital Days | -115.54 | 4.51 | 47.27 | 12.48 | 20.71 | 13.33 | 18.33 | 33.16 | 27.78 | 30.74 | 24.77 | 29.87 |
| ROCE % | -12.36% | 17.99% | 16.91% | 17.35% | 13.65% | 14.67% | 11.09% | 16.63% | 11.06% | 12.63% | 12.95% | 7.88% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.20 | 1.83 | 1.39 | 1.08 | 0.44 |
| Diluted EPS (Rs.) | 0.20 | 1.83 | 1.39 | 1.08 | 0.44 |
| Cash EPS (Rs.) | 0.86 | 2.65 | 2.02 | 1.64 | 1.30 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 17.77 | 17.60 | 15.89 | 14.47 | 5.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 17.77 | 17.60 | 15.89 | 14.47 | 5.11 |
| Revenue From Operations / Share (Rs.) | 91.68 | 150.19 | 100.02 | 85.61 | 53.58 |
| PBDIT / Share (Rs.) | 4.82 | 6.84 | 6.34 | 5.48 | 3.74 |
| PBIT / Share (Rs.) | 4.16 | 6.02 | 5.70 | 4.91 | 2.88 |
| PBT / Share (Rs.) | 0.36 | 2.68 | 2.00 | 1.58 | 0.28 |
| Net Profit / Share (Rs.) | 0.20 | 1.83 | 1.39 | 1.08 | 0.43 |
| PBDIT Margin (%) | 5.25 | 4.55 | 6.33 | 6.39 | 6.97 |
| PBIT Margin (%) | 4.53 | 4.00 | 5.70 | 5.73 | 5.37 |
| PBT Margin (%) | 0.39 | 1.78 | 1.99 | 1.84 | 0.53 |
| Net Profit Margin (%) | 0.22 | 1.21 | 1.39 | 1.25 | 0.81 |
| Return on Networth / Equity (%) | 1.14 | 10.37 | 8.75 | 7.43 | 8.58 |
| Return on Capital Employeed (%) | 16.17 | 22.87 | 23.95 | 23.85 | 16.73 |
| Return On Assets (%) | 0.25 | 2.41 | 2.12 | 1.65 | 0.85 |
| Long Term Debt / Equity (X) | 0.42 | 0.47 | 0.47 | 0.40 | 0.64 |
| Total Debt / Equity (X) | 2.25 | 1.71 | 1.86 | 2.10 | 3.99 |
| Asset Turnover Ratio (%) | 1.18 | 2.13 | 1.54 | 1.88 | 1.20 |
| Current Ratio (X) | 1.19 | 1.23 | 1.23 | 1.17 | 1.17 |
| Quick Ratio (X) | 0.32 | 0.28 | 0.30 | 0.42 | 0.40 |
| Inventory Turnover Ratio (X) | 2.09 | 3.33 | 2.37 | 3.08 | 1.82 |
| Interest Coverage Ratio (X) | 1.27 | 2.05 | 1.71 | 1.64 | 1.44 |
| Interest Coverage Ratio (Post Tax) (X) | 1.05 | 1.55 | 1.38 | 1.32 | 1.17 |
| Enterprise Value (Cr.) | 66.75 | 85.41 | 60.02 | 67.20 | 14.08 |
| EV / Net Operating Revenue (X) | 0.85 | 0.66 | 0.70 | 0.92 | 0.61 |
| EV / EBITDA (X) | 16.27 | 14.65 | 11.12 | 14.41 | 8.76 |
| MarketCap / Net Operating Revenue (X) | 0.44 | 0.47 | 0.42 | 0.57 | 0.23 |
| Price / BV (X) | 2.30 | 4.05 | 2.65 | 3.42 | 2.43 |
| Price / Net Operating Revenue (X) | 0.44 | 0.47 | 0.42 | 0.57 | 0.23 |
| EarningsYield | 0.00 | 0.02 | 0.03 | 0.02 | 0.03 |
After reviewing the key financial ratios for Axel Polymers Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 5. It has decreased from 1.83 (Mar 24) to 0.20, marking a decrease of 1.63.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 5. It has decreased from 1.83 (Mar 24) to 0.20, marking a decrease of 1.63.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 3. It has decreased from 2.65 (Mar 24) to 0.86, marking a decrease of 1.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.77. It has increased from 17.60 (Mar 24) to 17.77, marking an increase of 0.17.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.77. It has increased from 17.60 (Mar 24) to 17.77, marking an increase of 0.17.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 91.68. It has decreased from 150.19 (Mar 24) to 91.68, marking a decrease of 58.51.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 4.82. This value is within the healthy range. It has decreased from 6.84 (Mar 24) to 4.82, marking a decrease of 2.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.16. This value is within the healthy range. It has decreased from 6.02 (Mar 24) to 4.16, marking a decrease of 1.86.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.36. This value is within the healthy range. It has decreased from 2.68 (Mar 24) to 0.36, marking a decrease of 2.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 2. It has decreased from 1.83 (Mar 24) to 0.20, marking a decrease of 1.63.
- For PBDIT Margin (%), as of Mar 25, the value is 5.25. This value is below the healthy minimum of 10. It has increased from 4.55 (Mar 24) to 5.25, marking an increase of 0.70.
- For PBIT Margin (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 10. It has increased from 4.00 (Mar 24) to 4.53, marking an increase of 0.53.
- For PBT Margin (%), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 10. It has decreased from 1.78 (Mar 24) to 0.39, marking a decrease of 1.39.
- For Net Profit Margin (%), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 5. It has decreased from 1.21 (Mar 24) to 0.22, marking a decrease of 0.99.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 15. It has decreased from 10.37 (Mar 24) to 1.14, marking a decrease of 9.23.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.17. This value is within the healthy range. It has decreased from 22.87 (Mar 24) to 16.17, marking a decrease of 6.70.
- For Return On Assets (%), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 5. It has decreased from 2.41 (Mar 24) to 0.25, marking a decrease of 2.16.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.47 (Mar 24) to 0.42, marking a decrease of 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.25. This value exceeds the healthy maximum of 1. It has increased from 1.71 (Mar 24) to 2.25, marking an increase of 0.54.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.18. It has decreased from 2.13 (Mar 24) to 1.18, marking a decrease of 0.95.
- For Current Ratio (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 1.5. It has decreased from 1.23 (Mar 24) to 1.19, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.32, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.09. This value is below the healthy minimum of 4. It has decreased from 3.33 (Mar 24) to 2.09, marking a decrease of 1.24.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 3. It has decreased from 2.05 (Mar 24) to 1.27, marking a decrease of 0.78.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 3. It has decreased from 1.55 (Mar 24) to 1.05, marking a decrease of 0.50.
- For Enterprise Value (Cr.), as of Mar 25, the value is 66.75. It has decreased from 85.41 (Mar 24) to 66.75, marking a decrease of 18.66.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 24) to 0.85, marking an increase of 0.19.
- For EV / EBITDA (X), as of Mar 25, the value is 16.27. This value exceeds the healthy maximum of 15. It has increased from 14.65 (Mar 24) to 16.27, marking an increase of 1.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.44, marking a decrease of 0.03.
- For Price / BV (X), as of Mar 25, the value is 2.30. This value is within the healthy range. It has decreased from 4.05 (Mar 24) to 2.30, marking a decrease of 1.75.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.44, marking a decrease of 0.03.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Axel Polymers Ltd:
- Net Profit Margin: 0.22%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.17% (Industry Average ROCE: 16.69%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.14% (Industry Average ROE: 12.44%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.05
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.32
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.5 (Industry average Stock P/E: 35.07)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.25
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.22%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Plastic & Plastic Products | S.No.309, VIL Mokshi, Sankarda-Savli Road, Vadodra District Gujarat 391780 | cs@axelindia.com http://www.axelpolymers.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Gaurav Thanky | Chairman & Managing Director |
| Mrs. Dhara Gaurav Thanky | Non Executive Woman Director |
| Mr. Chirag Shah | Addnl.Non Exe.Independent Director |
| Mr. Ashok Shah | Addnl.Non Exe.Independent Director |